The presentations highlighted a shift from merely cataloguing late‑effects toward understanding their underlying causes and testing survivor‑focused interventions that could mitigate risk over decades after treatment.
Stephanie Dixon reported results from the ALLSTARS study (ALTE1631), a digital, rewards‑based physical‑activity program for young survivors. Participants in the intervention arm showed measurable fitness gains, but the data also underscored the challenge of creating durable, survivor‑tailored approaches.
In a separate analysis, Deborah Ogunsanmi used data from the St. Jude Lifetime Cohort Study (SJLIFE) to link exposure to platinum‑based chemotherapy with increased cardiovascular toxicity among adult survivors, reinforcing concerns about long‑term heart health after certain drug regimens.
Kateryna Petrykey presented research exploring how genetic susceptibility may influence adult body‑mass index in survivors, offering insight into the biological factors that interact with treatment exposures to shape lifelong health outcomes.
Michael Betti introduced a novel investigative framework for probing the mechanisms that drive the heightened risk of subsequent neoplasms in childhood cancer survivors, a late‑breaking session that could inform future preventive strategies.
Miguel Navarrete shared findings from the Childhood Cancer Survivor Study that connect social determinants, sleep quality, and psychological distress, suggesting that non‑medical factors play a significant role in survivorship well‑being.
Collectively, the studies illustrate a broader effort to integrate treatment history, genetics, lifestyle and socioeconomic context into survivorship care, with the goal of helping survivors live longer, healthier lives long after therapy ends.